Elderly patients undergoing major vascular surgery: Risk factors and medication associated with risk reduction
This study assesses risk factors in elderly vascular surgery patients and to evaluate whether perioperative cardiac medication can reduce postoperative mortality rate. In a cohort study, 1693 consecutive patients ≥65 years undergoing major non-cardiac vascular surgery were preoperatively screened for cardiac risk factors and medication. During follow-up (median: 8.2 years), mortality was noted. Hospital mortality occurred in 8.1% and long-term mortality in 28.5%. In multivariate analysis, age, coronary artery disease, heart failure, cerebrovascular disease, renal failure and diabetes were significantly associated with increased hospital and long-term mortality. Perioperative aspirin (OR: 0.53, 95% confidence interval: 0.34-0.83), β-blockers (OR: 0.32, 95% CI: 0.19-0.54) and statins (OR: 0.35, 95% CI: 0.18-0.68) were significantly associated with reduced hospital mortality. In addition, aspirin (HR: 0.65, 95% CI: 0.53-0.81), angiotensin-converting enzyme (ACE)-inhibitors (HR: 0.74, 95% CI: 0.59-0.92), β-blockers (HR: 0.61, 95% CI: 0.48-0.76) and statins (HR: 0.65, 95% CI: 0.49-0.87) were significantly associated with reduced long-term mortality. Heterogeneity tests revealed a gradient decrease of mortality risk in patients from low to high age using statins (p = 0.03). In conclusion, age is an independent predictor of hospital and long-term mortality in elderly patients undergoing major vascular surgery. Aspirin, ACE-inhibitors, β-blockers and statins reduce long-term mortality risk. Especially the very elderly may benefit from statin therapy.
|Keywords||Cardiac medication, Cardiovascular outcome, Elderly, Non-cardiac surgery, Risk factors|
|Persistent URL||dx.doi.org/10.1016/j.archger.2007.11.003, hdl.handle.net/1765/25029|
Feringa, H.H.H., Bax, J.J., Karagiannis, S.E., Noordzij, P., van Domburg, R.T., Klein, J., & Poldermans, D.. (2009). Elderly patients undergoing major vascular surgery: Risk factors and medication associated with risk reduction. Archives of Gerontology and Geriatrics, 48(1), 116–120. doi:10.1016/j.archger.2007.11.003